Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2003
08/14/2003CA2474431A1 Method of treating and preventing bone loss
08/14/2003CA2474429A1 Method and apparatus for performing submicroliter reactions with nucleic acids or proteins
08/14/2003CA2474145A1 Bacteriophage lysin
08/14/2003CA2473820A1 Method of production of astaxanthin by fermentation of selected strains of xanthophyllomyces dendrorhous
08/14/2003CA2473499A1 Minrs as modifiers of insulin receptor signaling and methods of use
08/14/2003CA2473182A1 Compositions and methods for treatment of vitamin d deficiency
08/14/2003CA2472765A1 Modulation of sulfate permease for photosynthetic hydrogen production
08/14/2003CA2472265A1 Immunogenic formulations of variable peptidic epitopes and process for preparation thereof
08/14/2003CA2467893A1 Modified antigen-presenting cells
08/14/2003CA2464527A1 Multivalent streptococcal vaccine compositions and methods for use
08/14/2003CA2459718A1 Thermus scotoductus nucleic acid polymerases
08/14/2003CA2451650A1 Ligands to enhance cellular uptake of biomolecules
08/14/2003CA2445291A1 Prevention of transgene escape in genetically modified perennials
08/13/2003EP1335028A2 Multi-test analysis of real-time nucleic acid amplifications
08/13/2003EP1335027A1 Method of quantifying genetic modification and standard molecule to be used therein
08/13/2003EP1335024A1 Antibody inhibiting vplf activity
08/13/2003EP1335023A2 Methods and reagents for vaccination which generate a CD8 T cell immune response
08/13/2003EP1335022A1 Modification of plant cell wall component and method of regulating development differentiation
08/13/2003EP1335021A1 Genomes participating in rheumatoid arthritis, method of the diagnosis thereof, method of evaluating the onset possibility thereof, diagnostic kit for detecting them and therapeutic method and remedies for rheumatoid arthritis
08/13/2003EP1335020A1 Polypeptides having alpha-isomaltosyl transferase activity
08/13/2003EP1334984A1 Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof
08/13/2003EP1334981A2 Method for purifying keratinocyte growth factors
08/13/2003EP1334980A1 Multimerized highly functional antifreeze protein
08/13/2003EP1334979A1 Gene conferring resistance to Phytophthera infestans (late-blight) in Solanaceae
08/13/2003EP1334730A2 Platelet-specific chimeric immunoglobulin and methods of use therefor
08/13/2003EP1334659A1 Pd-1-lacking mouse and use thereof
08/13/2003EP1334358A1 Targeting cells having mad2 mutation for treatment and/or prevention of disease
08/13/2003EP1334356A2 Method for generating cloned animals using chromosome shuffling
08/13/2003EP1334212A1 Apparatus and method for analysing chemical samples
08/13/2003EP1334211A1 Method for analysing a patient's predisposition to insulin-dependent diabetes, device and set of primers
08/13/2003EP1334210A2 Genetic test for the identification of carriers of complex vertebral malformations in cattle
08/13/2003EP1334209A2 Nucleic acid amplification-based methods for the determination of a methylation profile and reagents therefor
08/13/2003EP1334202A2 PROCESS FOR THE PREPARATION OF i TRANS /i -CARVEOL
08/13/2003EP1334201A2 Dna expression vectors
08/13/2003EP1334200A2 Multiple inducible gene regulation system
08/13/2003EP1334199A1 A transformation system in camelina sativa
08/13/2003EP1334198A2 Enzymes and encoding genes from methylophilus methylotrophus
08/13/2003EP1334197A1 Yeast derived vaccine against ipnv
08/13/2003EP1334196A2 Genomic fragment of streptococcus suis and clinical uses thereof
08/13/2003EP1334195A2 Analogues, agonists, antagonists and variants of the oxidoreductase enzyme activity of the macrophage-migration inhibition factor (mif) as immunomodulators, medicaments, diagnostics and screening agents in inflammatory and immune diseases
08/13/2003EP1334194A2 Imaging, diagnosis and treatment of disease
08/13/2003EP1334193A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/13/2003EP1334192A2 Cystoskeleton-associated proteins
08/13/2003EP1334191A2 Human g-protein coupled receptor and uses thereof
08/13/2003EP1334190A2 Human g-protein coupled receptor and uses thereof
08/13/2003EP1334189A2 Molecules involved in the regulation of insulin resistance syndrome (irs)
08/13/2003EP1334188A2 Cd19-specific redirected immune cells
08/13/2003EP1334187A2 C. elegans genes involved in viability and/or reproduction and uses thereof
08/13/2003EP1334186A2 Nucleic acid generating the abca7 gene, molecules modulating its activity and therapeutic applications
08/13/2003EP1334184A1 A combined electroporation and microinjection method for the penetration of lipid bilayer membranes
08/13/2003EP1334183A2 NOVEL SOLUBLE ENDOPROTEASES FOR THE i IN VITRO /i PROCESSING OF RECOMBINANT PROTEINS
08/13/2003EP1334182A2 Method of producing non-bovine chymosin and use hereof
08/13/2003EP1334181A2 Production of medium chain length polyhydroxyalkanoates from fatty acid biosynthetic pathways
08/13/2003EP1334180A1 Isocitrate dehydrogenase, gene thereof, and use of the same in the treatment of obesity, hyperlipidemia, and fatty liver in lipid biosynthesis
08/13/2003EP1334179A2 A human serpin secreted from lymphoid cells lsi-01
08/13/2003EP1334178A1 Slo2 and slo4, novel potassium channel proteins from human brain
08/13/2003EP1334174A2 Paramyxovirus vector for gene transfer to the cardiovascular system
08/13/2003EP1334131A1 Monoclonal antibodies to the map protein and method of use in treating or preventing infections
08/13/2003EP1334130A2 Regulation of human serotonin receptor precursor
08/13/2003EP1334129A2 Methods of screening for ltrpc2 modulators
08/13/2003EP1334126A1 Human stra6-like protein and nucleic acids encoding the same
08/13/2003EP1334123A2 Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases
08/13/2003EP1334122A2 Nucleic acids encoding stichodactylidae chromoproteins
08/13/2003EP1334120A2 Modified clostridial neurotoxins with altered biological persistence
08/13/2003EP1334112A2 Cell lines expressing a mch receptor
08/13/2003EP1334110A2 Methods for isolating one strand of a double-stranded nucleic acid
08/13/2003EP1333857A2 IMMUNOGENIC HBc CHIMER PARTICLES HAVING ENHANCED STABILITY
08/13/2003EP1333853A1 Growth factor complex
08/13/2003EP1333845A1 Treatment of t cell disorders
08/13/2003EP1333841A2 M. tuberculosis chaperonin 10 and uses thereof
08/13/2003EP1333840A2 M. tuberculosis chaperonin 60.1 and uses thereof
08/13/2003EP1333834A2 Antiinflammation agents
08/13/2003EP1333719A2 Corticotropin releasing factor receptor 2 deficient mice and uses thereof
08/13/2003EP1254271A4 Methods for the storage and synthesis of nucleic acids
08/13/2003EP1106685B1 Apparatus for extracting and processing gene motif, method for extracting and processing gene motif and recording medium carrying gene motif extraction/processing program
08/13/2003EP1023306B1 System and method for performing polynucleotide separations using liquid chromatography
08/13/2003EP1012324A4 Promiscuous g-protein compositions and their use
08/13/2003EP0989859B1 Cns neuroregenerative compositions and methods of use
08/13/2003EP0859629B1 Phosphorylated recombinant human beta casein for inhibition of attachment of h. influenzae to human cells
08/13/2003EP0820465B1 Bioprocess for production of dipeptide based compounds
08/13/2003EP0742838B1 Methods for the elimination of dna sequencing artifacts
08/13/2003EP0695361B1 Expression of heterologous genes according to a targeted expression profile
08/13/2003EP0669980B1 Method of controlling polypeptide production in bacteria
08/13/2003EP0667959B1 Methods for identifying inhibitors of the production of beta-amyloid peptide
08/13/2003EP0614374B1 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES
08/13/2003EP0580692B1 Autoinducer
08/13/2003EP0575491B1 Genetically engineered vaccine strain
08/13/2003EP0572553B1 Recombinant thrombin receptor and related pharmaceuticals
08/13/2003EP0531472B1 Humanized monoclonal antibodies
08/13/2003CN1436248A Detection of mycosphaerella using polymerase chain reaction
08/13/2003CN1436247A Methods for clinical diagnosis
08/13/2003CN1436246A Method for preparing physiologically active IL-18 polypeptide
08/13/2003CN1436243A Endoglucanase NCE5 and cellulase preparations contg. same
08/13/2003CN1436242A Expression-regulating sequences and expression products in field of filamentous fungi chrysosporium
08/13/2003CN1436241A Sphingosine kinase and uses thereof
08/13/2003CN1436240A Process for producing ethanol by using recombinant coryneform bacterium
08/13/2003CN1436239A Novel enzyme gene and its expression product
08/13/2003CN1436238A Anti-listeria bacteriocin
08/13/2003CN1436237A Nucleotide sequences involved in increasing or decreasing mammalian ovulation rate
08/13/2003CN1436236A Gasci基因 Gasci gene
1 ... 2452 2453 2454 2455 2456 2457 2458 2459 2460 2461 2462 2463 2464 2465 2466 2467 2468 2469 2470 2471 2472 ... 4023